Tender For supply of essential drugs d d - linagliptine tablet 5 mg , rifaximine tablet 550 mg , sodium chloride injection 500 ml 0.9 percent , iron folic acid , coagulation factor viii powder for injection 250 iu
Tender For corrigendum : e-bid for rate contract cum supply and empanelment of firms for drugs and medicines - zinc sulphate dispersible tablets ip elemental zinc 10 mg [472, cefixime oral suspension ip 25mg/ml (paediatric drops) [511], recombinant coagulation factor viia 1mg [690], iron and folic acid syrup ip each ml of syrup contains ferrous sulphate ip equivalent to elemental ferrous iron 20mg, folic acid ip 0.1mg with any flavour [448w], azithromycin tablets ip 250mg [79a], ceftriaxone 1000mg and salbactum 500mg and disodium edetate 37mg inj [nrd-185], durvalumab 120 mg inj. [nrd-222], durvalumab 500mg inj. [nrd-223], insulin aspart 100iu/ml injection 3 ml [nrd-258], ruxolitinib 5 mg tablet / capsule [nrd-772], ruxolitinib 15 mg tablet / capsule [nrd-774], ruxolitinib 20 mg tablet / capsule. [nrd-775], glycopegylated extended half life nonacog beta pegol f ix 500 iu [nrd-889], glycopegylated extended half life nonacog beta pegol f ix 1000 iu [nrd-890], glycopegylated extended half life factor viii 500 iu [nrd-891], glycopegylated extended half life factor viii 1000 iu
Tender For retender for providing testing/analysis services for drugs, chemicals and miscellaneous items by nabl acredited laboratories or approved by the competant authority - diphtheria + tetanus vaccine (adsorbed) for adults and adolescents ip each 0.5 ml contains diphtheria toxoid 2iu tetanus toxoid5lf to25 lf or20iu absorbed on aluminum phosphate1x0.5 ml vial/ampoule, epiduralminipack 18g, 80mm-90mm, metal stylet for single use only, sterile 1x1, montelukast and levocetrizine tablet ip (montelukast 4 mg+levocetrizine 2.5 mg ) 1x1, human hepatitis b immunoglobulin (hbig) vaccine 100iu/ml 1x1ml vial, biocide-bacillus thuringiensis israelensis(bti) wp (for polluted & non polluted water) 1x10 kgs, medicine boxes na na 1x1, digital hemoglobinometer na na 1x1, sickle cell screen kit rapid test 1x1, rtpcr kits for sars cov-2 (covid-19) na each kit (1x100 test) 1x1 kit, rapid diagnostic test ( bi-valent ) kit for diagnosis of both p.vivax and p.falciparum simultaneously 1x10 kits, nsi dengue antigen elissa kit 12x8 ( 96 well per plate/kit ) 1x1, multiplex influenza pcr kits (for detecting influenza a, influenza a (h1n1), influenza a(h3n2), influenza b, sars-cov-2 and rsv) kit (25 kits with 100 tests in each kit) na 1x1, hiv+syphilis (antibodies to hiv1&2) combi kit na 1x1 kit each testing kit should contain a) testing device-50 nos b) sterile lancet-50nos c) alcohol swab-50nos d) dropper-50nos e) sample diluent-1nos, hcv antibody test (anti hcv) for hepatitis c (rapid test) test kit na 1x1 kit each testing kit should contain a) testing device-50 nos b) sterile lancet-50nos c) alcohol swab-50nos d) dropper-50nos e) sample diluent-1nos, hbsag test for hepatitis b kit rapid test 1x1, haemoglobin (strip) testing kit containing one digital hemoglobinometer1x1 one pack insert along with device. kit 1x1 kit 1x1, haemoglobin (strip) testing kit containing haemoglobin strips 1x50nos sterile lancets 1x50nos alcohol swab 1x50 nos kit 1x1 kit 1x1, compatible test strips for digital hemoglobinometer with lancets na na 1x1, blood glucose testing kit containing one digital glucometer 1x1and one pack insert along with device. kit 1x1 kit 1x1, blood glucose testing kit containing blood glucose testing strips 1x50nos,sterile lancets 1x50nos alcohol swab 1x50 nos, kit 1x1 kit 1x1, automated rna extraction kits (compatible kit for k flex) kits na 1x1, tenecteplase (tnk-tpa) for injection 30mg kit containing a. tenecteplase (tnk-tpa) lyophilized powder for injection 30 mg b. sterile water for injection ip 10 ml c. disposable hypodermic syringes d. disposable hypodermic needles e. isopropyl alcohol swab 1x1, ultra pure recombinant factor 8-plasma free,human albumin free injection 500iu 1x1, ultra pure recombinant factor 8-plasma free,human albumin free injection 250iu 1x1, ultra pure recombinant factor 8-plasma free,human albumin free injection 1000 iu 1x1, human coagulation factor ix injection ip 600iu 1x1 vial with sterile water for injection, plasma derived intermideate purity injection factor 8 enriched withvon willebrand factor ( for persons with vwd) injection 500iu 1x500 iu, plasma derived intermediate purity injection factor 8 enriched with von willebrand factor ( for persons with vwd) injection 250iu 1x250 iu, factor viii mimic emicizumab ( subcutaneous ) injection 60mg/0.4ml 1x1 vial, factor viii mimic emicizumab ( subcutaneous ) injection 30mg/ml 1x1 vial, factor viii mimic emicizumab ( subcutaneous ) injection 150mg/ml 1x1 vial, factor viii mimic emicizumab ( subcutaneous ) injection 105mg/0.7ml 1x1 vial, dried factor viii fraction ip 500iu 1x1vial, dried factor viii fraction ip 250iu 1x1vial, coagulant factor viii (recombinant) rfviii (plasma/albumin free method) injection ip 500iu 1x1, coagulant factor viii (recombinant) rfviii (plasma/albumin free method) injection ip 1500iu 1x1, coagulant factor viii (recombinant) rfviii (plasma/albumin free method) injection ip 1000 iu 1x1, activated human recombinant coagulation factorvii-1mg injections